Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Accenture
Chinese Patent Office
Moodys
Fuji
Express Scripts
McKesson
Covington
Colorcon
Mallinckrodt

Generated: January 17, 2018

DrugPatentWatch Database Preview

Homatropine methylbromide; hydrocodone bitartrate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for homatropine methylbromide; hydrocodone bitartrate and what is the scope of homatropine methylbromide; hydrocodone bitartrate patent protection?

Homatropine methylbromide; hydrocodone bitartrate
is the generic ingredient in five branded drugs marketed by Endo Pharms, Abhai Llc, Actavis Mid Atlantic, Bio-pharm Inc, Hi Tech Pharma, Ivax Sub Teva Pharms, Novel Labs Inc, Paddock Llc, Wockhardt, Halsey, Actavis Elizabeth, Avanthi Inc, and King Pharms, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for homatropine methylbromide; hydrocodone bitartrate. Fourteen suppliers are listed for this compound.
Summary for homatropine methylbromide; hydrocodone bitartrate
Pharmacology for homatropine methylbromide; hydrocodone bitartrate

US Patents and Regulatory Information for homatropine methylbromide; hydrocodone bitartrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
King Pharms TUSSIGON homatropine methylbromide; hydrocodone bitartrate TABLET;ORAL 088508-001 Jul 30, 1985 AA RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Endo Pharms HYCODAN homatropine methylbromide; hydrocodone bitartrate SYRUP;ORAL 005213-002 Jul 26, 1988 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Endo Pharms HYCODAN homatropine methylbromide; hydrocodone bitartrate TABLET;ORAL 005213-001 Jul 26, 1988 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Novel Labs Inc HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE homatropine methylbromide; hydrocodone bitartrate TABLET;ORAL 091528-001 Apr 20, 2011 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wockhardt HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE homatropine methylbromide; hydrocodone bitartrate SYRUP;ORAL 088008-001 Mar 3, 1983 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Novel Labs Inc HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE homatropine methylbromide; hydrocodone bitartrate SYRUP;ORAL 203535-001 Feb 13, 2017 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Elizabeth HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE homatropine methylbromide; hydrocodone bitartrate TABLET;ORAL 040295-001 Dec 1, 2000 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Halsey HYDROPANE homatropine methylbromide; hydrocodone bitartrate SYRUP;ORAL 088066-001 Jun 28, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bio-pharm Inc HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE homatropine methylbromide; hydrocodone bitartrate SYRUP;ORAL 204765-001 Mar 6, 2017 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abhai Llc HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE homatropine methylbromide; hydrocodone bitartrate SYRUP;ORAL 207487-001 Feb 21, 2017 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Mallinckrodt
Farmers Insurance
Merck
Cantor Fitzgerald
McKinsey
US Department of Justice
QuintilesIMS
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot